ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN MYOCARDIAL INFARCTION: RESULTS OF THE SMILE STUDY PROJECT

详细

The long-term SMILE study project using zofenopril has demonstrated that it is expedient and safe to early use the drug in hemodynamically stable patients with anterior myocardial infarction receiving no thrombolytic therapy and provided evidence that the specific features of individual angiotensin-converting enzyme inhibitors, which are associated with their chemicopharmacological properties, are of clinical value.